Cargando…
Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials
INTRODUCTION: The previous meta-analysis on the use of endothelin-receptor antagonists (ETRAs) to treat aneurysmal subarachnoid hemorrhage (SAH) has become outdated due to recently published phase 3 clinical trials. An up-to-date meta-analysis is needed to provide the best available evidence for the...
Autores principales: | Ma, Junpeng, Huang, Siqing, Ma, Lu, Liu, Yi, Li, Hao, You, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682300/ https://www.ncbi.nlm.nih.gov/pubmed/23078672 http://dx.doi.org/10.1186/cc11686 |
Ejemplares similares
-
Clinicians' preferences for managing aneurysmal subarachnoid hemorrhage using endothelin receptor antagonists
por: Heidenreich, Sebastian, et al.
Publicado: (2023) -
Endothelin antagonists in subarachnoid hemorrhage: what next?
por: Macdonald, R Loch
Publicado: (2012) -
Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: an updated meta-analysis
por: Lee, Keng Siang, et al.
Publicado: (2023) -
The effect of fenestration of the lamina terminalis on the incidence of shunt-dependent hydrocephalus after aneurysmal subarachnoid hemorrhage (FISH): Study protocol for a randomized controlled trial
por: Tao, Chuanyuan, et al.
Publicado: (2016) -
Identification of the key immune-related genes in aneurysmal subarachnoid hemorrhage
por: Wang, Xing, et al.
Publicado: (2022)